RhumbLine Advisers’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

RhumbLine Advisers’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-98,339	Closed	-$17M	–	3199
2015 Q1	$17M	Buy	98,339 +7,810	+9%	+$1.15M	0.05%	351
2014 Q4	$10.4M	Buy	90,529 +1,197	+1%	+$145K	0.03%	482
2014 Q3	$14M	Sell	89,332 -2,851	-3%	-$413K	0.04%	383
2014 Q2	$11.4M	Sell	92,183 -4,427	-5%	-$489K	0.03%	450
2014 Q1	$10M	Sell	96,610 -1,942	-2%	-$199K	0.03%	504
2013 Q4	$8.86M	Sell	98,552 -7,619	-7%	-$608K	0.03%	533
2013 Q3	$7.1M	Buy	106,171 +37,012	+54%	+$2.55M	0.02%	645
2013 Q2	$4.58M	Buy	+69,159	New	+$3.96M	0.01%	813

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

RhumbLine Advisers's SLXP Position: Q2 2015 in Review

RhumbLine Advisers sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 98,339 shares — an estimated $17M sold.

RhumbLine Advisers first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $17M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

RhumbLine Advisers reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
RhumbLine Advisers sold 98,339 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $17M.
RhumbLine Advisers first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
RhumbLine Advisers's SALIX PHARMACEUTICALS LTD DEL position peaked at $17M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on RhumbLine Advisers's 13F filing for Q2 2015, filed 4 Aug 2015.